Along the same line, i was scanning (for fun) the Monday edition of IBD, and in particular the Nasdaq quotes.
of all the nasdaq stocks that i looked at, i did not see a single one, repeat a single one stock that could surpass IMRS in the combined strength in EPS, RS, Acc. Distribution, % Ann Grth, Qtr EPS % change, Qtr Sales % change, Ann. Ern Est.
check it out if you have monday's IBD.
the only criteria that was not exceptionally strong was the acc. distr., which was a 'B'. but of course, had that been an 'A', then the stock would be in the high thirties by now.
FWIW. |
